Searched for
PANACEA BIOTEC JOINT
Panacea Biotec supplies second component of Sputnik V vaccine in IndiaThe second component of Sputnik V has been manufactured at the company's vaccine manufacturing facility in Himachal Pradesh, Panacea Biotec...- Panacea Biotec soars 5% as production of Sputnik V kicks offShares of Panacea Biotec have delivered 190 per cent return in the last one year, soaring from Rs 141.5 to Rs 407.2. The counter has more t...
- RDIF, Panacea Biotec to produce 100 million doses of Sputnik V vaccine in India per yearIndian biotech firm Panacea Biotec Ltd has agreed to produce 100 million doses of Russia's Sputnik V COVID-19 vaccine annually.
- Panacea Biotec joins hands with US-based Refana to develop COVID-19 vaccineThe company is advancing its response to address the unprecedented challenges of COVID-19 by collaborating with Refana Inc to make a vaccin...
- Panacea Biotec gets USFDA nod to launch Prasugrel tabletsThe product has been launched in the market by Apotex Corp, which is the exclusive sales and distribution partner for this product in US, P...
- Panacea Biotec, US's Bionpharma join hands for 7 drugsUnder the collaboration, Panacea will be responsible for development, filing, registration, manufacturing and supply of these ANDAs, the co...
- Panacea Biotec launches diabetes drug 'Tenepan'Tenapan aims to improve accessibility of diabetes treatment at an affordable cost as part of the company's commitment to the 'Make in India...
- Panacea launches prostate cancer drugDrug firm Panacea Biotec today launched Cabapan injection, an indigenously developed drug for treating prostate cancer.
- Panacea Biotec enters into collaboration for generic productPanacea Biotec said it has entered into a collaboration with an international pharmaceutical company for development and supply of a generi...
- Panacea enters into alliance with Canada based Apotex IncCommenting on the development, Panacea Biotec Joint MD Rajesh Jain said: "This strategic alliance with Apotex is one of the cardinal milest...
- Panacea Biotec Q3 net profit at Rs 83 crorePanacea Biotec today posted a net profit of Rs 82.79 crore for the third quarter ended December 31, 2013.
- Panacea Biotec Q3 net loss at 71.72 crThe company had posted a net profit of Rs 42.60 crore for the quarter ended December 31, 2010, Panacea Biotec said in a filing to BSE.
- Panacea Biotec Q1 net dips 48.63 pc to Rs 16.72 crPanacea Biotec today said its net profit declined by 48.63 per cent to Rs 16.72 crore for the quarter ended June 30, 2011 over the same per...
- Laboratorios to market Panacea drug in EuropePanacea Biotec has signed a non-exclusive marketing agreement with Uruguay's Laboratorios Clausen SA, allowing the Latin American firm to m...
- Panacea Biotec Q3 net up over five-fold to Rs 42.60 crPanacea Biotec today said its net profit zoomed over five-fold to Rs 42.60 crore for the third quarter ended December 31, 2010, over the sa...
- Panacea June quarter net profit zooms two-fold to Rs 32 crDrug-maker Panacea Biotec on Tuesday said net profit surged over two-fold to Rs 32.55 crore for the quarter ended June 30.
- Panacea to buy 19.9% in PharmAthene for $13.1 mnVaccine maker Panacea Biotec has agreed to buy 19.9% in US-based PharmAthene for $13.1 mn.
- Panacea enters into alliance with US-based PharmAtheneVaccine manufacturer Panacea Biotec on Wednesday said it has entered into a strategic alliance with US-based PharmAthene and will invest 13...
- Panacea Biotec enters hospital bizVaccine maker Panacea Biotec is foraying into the hospital business by setting up a 220-bed multi-specialty hospital with Gurgaon-based Umk...
- Panacea Biotec signs MoU with Panjab UniversityPanacea Biotec today said it has entered into an agreement with Panjab University to carry out research activities related to drug discover...
Load More
